Fortis Healthcare Q2FY27 Results: Revenue at ₹2,735 Cr, PAT at ₹317 Cr
Fortis Healthcare reported Q2 FY27 consolidated revenue of ₹2,735 crore, up 17.3% YoY. PAT stood at ₹317 crore, a 3.8% increase. H1 FY27 revenue reached ₹5,280 crore, up 17.4%. The company also acquired Suguna Hospital for ~₹277 crore and entered an agreement for a new hospital in Delhi.
The announcement includes significant financial performance metrics and key strategic developments such as acquisitions and new hospital agreements, which are material to investors.
The company reported strong year-on-year revenue growth in both Q2 and H1 FY27, along with strategic acquisitions and expansion plans, indicating positive business momentum.
Fortis Healthcare Limited has announced its financial results for the quarter and half-year ended September 30, 2026. The company reported a consolidated revenue of ₹2,735 crore for Q2 FY27, a 17.3% increase compared to ₹2,331 crore in Q2 FY26. Profit Before Tax (PBT) stood at ₹429 crore, up 4.0% from ₹402 crore in the same period last year. Consolidated Profit After Tax (PAT) was ₹317 crore, a marginal increase of 3.8% from ₹305 crore in Q2 FY26. The PAT margin for the quarter was 11.6% compared to 13.1% in the prior year.
For the half-year ended September 30, 2026 (H1 FY27), consolidated revenue grew by 17.4% to ₹5,280 crore from ₹4,498 crore in H1 FY26. PBT increased by 5.8% to ₹783 crore from ₹740 crore, and PAT saw a 3.8% rise to ₹581 crore from ₹559 crore. The PAT margin for H1 FY27 was 11.0% compared to 12.4% in H1 FY26.
In recent updates, Fortis Healthcare entered into definitive agreements to provide healthcare services at a new 400+ bedded super-specialty hospital in Ashok Vihar, New Delhi, under a 29-year Healthcare Services Agreement. Additionally, the company acquired Suguna Hospital, a 110-bedded facility in Rajajinagar, Bengaluru, for approximately ₹277 crore in an all-cash deal.
The hospital business reported revenues of ₹2,340 crore in Q2 FY27, an 18.6% increase year-on-year. The diagnostics business (Agilus) reported gross revenues of ₹448 crore, a 12.2% growth over Q2 FY26.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.